O

Oviedo Medical Research | Oviedo, FL

Research site
(Unclaimed)
Location
2441 W. State Road 426, Suite 2011, Oviedo, Florida, United States of America
Site insights

Top conditions

Diabetes Mellitus (11 trials)

Type 2 Diabetes Mellitus (10 trials)

Overweight (5 trials)

Obesity (5 trials)

Hypogonadism (3 trials)

Top treatments

Tirzepatide
Metformin
Semaglutide
LY3298176
Testosterone Undecanoate
Sugar
Linaclotide
JZP-110
Dulaglutide
Cagrilintide

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

10 of 32
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Tirzepatide in People With Type 2 Diabetes Treated With Metformin With or Without an SGLT2 Inhibitor

This study will look at how well CagriSema helps people with type 2 diabetes lower their blood sugar and body weight. CagriSema is a new investigatio...

Enrolling
Type 2 Diabetes
Drug: Tirzepatide
Drug: Cagrilintide

This study will look at how much weight participants will lose and how much blood sugar control they achieve from the start to the end of the study....

Active, not recruiting
Obesity
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo

The study will look at how well CagriSema helps people lower their blood sugar and body weight. CagriSema is a new weekly medicine that combines two...

Enrolling
Type 2 Diabetes Mellitus
Drug: Cagrilintide
Drug: Semaglutide

This study will look at how well the new medicine CagriSema helps people living with excess body weight and type 2 diabetes losing weight. Participan...

Active, not recruiting
Overweight
Type 2 Diabetes Mellitus
Drug: Cagrilintide
Drug: Placebo cagrilintide

The main purpose of this study is to evaluate the efficacy and safety of tirzepatide for the maintenance of body weight reduction.

Active, not recruiting
Overweight
Obesity
Drug: Tirzepatide
Drug: Placebo

This is a study of tirzepatide in participants with overweight and obesity. The main purpose is to learn more about how tirzepatide affects body weig...

Active, not recruiting
Overweight
Obesity
Drug: Tirzepatide
Drug: Placebo

Trial Title A randomized, double blind sham controlled clinical trial to evaluate the efficacy of vestibular nerve stimulation (VeNS), together with...

Active, not recruiting
Type 2 Diabetes
Device: Vestal DM Active device
Behavioral: Lifestyle modification

The objective of LIN-MD-64 is to evaluate the safety and efficacy of 12 weeks of linaclotide therapy (72 μg daily) in comparison with placebo in pedi...

Active, not recruiting
Functional Constipation
Irritable Bowel Syndrome With Constipation
Drug: Placebo (FC Participants)
Drug: Linaclotide 145 μg (IBS-C Participants)

LIN-MD-66 is a Phase 3 open-label study with 24 weeks (Functional Constipation participants) or 52 weeks (Irritable bowel syndrome with constipation...

Invitation-only
Functional Constipation
Irritable Bowel Syndrome With Constipation
Drug: Irritable Bowel Syndrome with Constipation (IBS-C) participants (LIN-MD-63 completers)
Drug: Functional Constipation (FC) participants (LIN-MD-62 and LIN-MD-64 completers)

Study CKJX839B12302 is a pivotal Phase III trial to evaluate the benefits of inclisiran on major adverse cardiovascular (MACE) events in participants...

Active, not recruiting
Atherosclerotic Cardiovascular Disease
Drug: Placebo
Drug: Inclisiran sodium 300 mg

Trial sponsors

Novo Nordisk logo

Novo Nordisk (6 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems